365 related articles for article (PubMed ID: 8972028)
1. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
Nakatanl S; Hato T; Minamoto Y; Fujita S
Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
[TBL] [Abstract][Full Text] [Related]
2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
3. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
5. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
7. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
Savi P; Zamboni G; Rescanières O; Herbert JM
Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508
[TBL] [Abstract][Full Text] [Related]
8. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
9. Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa.
Liu LX; Nardi MA; Nierodzik ML; Karpatkin S
Br J Haematol; 1995 Dec; 91(4):976-82. PubMed ID: 8547151
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa.
Mazurov AV; Khaspekova SG; Byzova TV; Tikhomirov OYu ; Berndt MC; Steiner B; Kouns WC
FEBS Lett; 1996 Aug; 391(1-2):84-8. PubMed ID: 8706936
[TBL] [Abstract][Full Text] [Related]
11. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
12. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa.
Tokita S; Arai M; Yamamoto N; Katagiri Y; Tanoue K; Igarashi K; Umeda M; Inoue K
Thromb Haemost; 1996 Jan; 75(1):168-74. PubMed ID: 8713797
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
15. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
16. Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist.
Cox D; Aoki T; Seki J; Motoyama Y; Yoshida K
Thromb Haemost; 1996 Mar; 75(3):503-9. PubMed ID: 8701416
[TBL] [Abstract][Full Text] [Related]
17. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
18. Platelet-fibrinogen interactions.
Bennett JS
Ann N Y Acad Sci; 2001; 936():340-54. PubMed ID: 11460491
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
Sloan SM; Brown EB; Liu Q; Frojmovic MM
Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
[TBL] [Abstract][Full Text] [Related]
20. "Bridged" peptide of fibrinogen binds to platelets activated by RGD peptide as well as by ADP.
Mohri H; Ohkubo T
Peptides; 1994; 15(4):683-7. PubMed ID: 7937346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]